Ketogenic Diet for Refractory Childhood Epilepsy: Beyond Seizures Control, the Experience of a Portuguese Pediatric Centre

Detalhes bibliográficos
Autor(a) principal: Romão Luz, Inês
Data de Publicação: 2019
Outros Autores: Pereira, Cristina, Garcia, Paula, Ferreira, Fátima, Faria, Ana, Macedo, Cristiane, Diogo, Luísa, Robalo, Conceição
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/12184
Resumo: Introduction: Ketogenic diet is a low carbohydrate diet, which can be used as a treatment for refractory childhood epilepsy. The first aim of this study was to evaluate its efficacy, in patients receiving ketogenic diet for at least three months, on epilepsy control, behaviour and awareness. The secondary aims were to evaluate the variation in the number of antiepileptic drugs, reasons for discontinuing the diet and adverse effects.Material and Methods: Retrospective analysis of clinical records of patients who underwent ketogenic diet for refractory epilepsy, from October 2007 to January 2018, in a tertiary pediatric hospital.Results: In the twenty-nine eligible patients, the mean age of initiation was 7.9 years-old (+/– 5.6). Of those, 18 had a ≥ 50% reduction of seizure activity, 19 a marked behaviour improvement and 18 improved awareness. The median number of antiepileptic drugs remained equal for the 15 patients who completed 18 months of treatment (three drugs). The main reason for discontinuing ketogenic diet was a familiar decision. The main adverse effects were hypercholesterolemia (n = 23) and hypertriglyceridemia (n = 21).Discussion: Results were comparable to those of other cohorts, namely age of initiation, proportion of patients completing ketogenic diet, most frequent reasons for stopping and significant improvement of alertness and behavior.Conclusion: Beyond seizure control, patients experienced a marked improvement in behavior and awareness. It is necessary to develop strategies to increase the adherence of families to the diet.
id RCAP_71275e32b0053fb22015b36bff68f2ef
oai_identifier_str oai:ojs.www.actamedicaportuguesa.com:article/12184
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling Ketogenic Diet for Refractory Childhood Epilepsy: Beyond Seizures Control, the Experience of a Portuguese Pediatric CentreDieta Cetogénica na Epilepsia Infantil Refratária: Para além do Controlo das Crises, Experiência de um Centro Pediátrico PortuguêsChildDietKetogenicDrug Resistant Epilepsy/diet therapyPortugalCriançaEpilepsia Resistente a Medicamentos/dietoterapiaPortugalIntroduction: Ketogenic diet is a low carbohydrate diet, which can be used as a treatment for refractory childhood epilepsy. The first aim of this study was to evaluate its efficacy, in patients receiving ketogenic diet for at least three months, on epilepsy control, behaviour and awareness. The secondary aims were to evaluate the variation in the number of antiepileptic drugs, reasons for discontinuing the diet and adverse effects.Material and Methods: Retrospective analysis of clinical records of patients who underwent ketogenic diet for refractory epilepsy, from October 2007 to January 2018, in a tertiary pediatric hospital.Results: In the twenty-nine eligible patients, the mean age of initiation was 7.9 years-old (+/– 5.6). Of those, 18 had a ≥ 50% reduction of seizure activity, 19 a marked behaviour improvement and 18 improved awareness. The median number of antiepileptic drugs remained equal for the 15 patients who completed 18 months of treatment (three drugs). The main reason for discontinuing ketogenic diet was a familiar decision. The main adverse effects were hypercholesterolemia (n = 23) and hypertriglyceridemia (n = 21).Discussion: Results were comparable to those of other cohorts, namely age of initiation, proportion of patients completing ketogenic diet, most frequent reasons for stopping and significant improvement of alertness and behavior.Conclusion: Beyond seizure control, patients experienced a marked improvement in behavior and awareness. It is necessary to develop strategies to increase the adherence of families to the diet.Introdução: A dieta cetogénica é uma dieta com baixo teor de hidratos de carbono, que pode ser usada no tratamento da epilepsia infantil refratária. O principal objetivo deste estudo foi avaliar a eficácia nos doentes que completaram pelo menos três meses de dieta, no que respeita ao controlo das crises, comportamento e estado de alerta. Foi também avaliada a variação do número de fármacos antiepiléticos, as razões de descontinuação e os efeitos secundários.Material e Métodos: Análise retrospetiva dos processos clínicos dos doentes com epilepsia refratária sob dieta cetogénica, de outubro de 2007 a janeiro de 2018, num hospital pediátrico de nível 3. Resultados: Nos 29 doentes elegíveis, a média da idade de implementação foi 7,9 anos (+/– 5,6). Destes, 18 tiveram uma redução ≥ 50% das crises, 19 tiveram uma melhoria marcada do comportamento e 18 do seu estado de alerta. Dos 15 que completaram 18 meses, a mediana do número de fármacos antiepiléticos permaneceu idêntica à do início (três fármacos). A principal razão de descontinuação foi por decisão familiar. Os principais efeitos secundários foram a hipercolesterolémia (n = 23) e a hipertrigliceridémia(n = 21).Discussão: Os resultados foram semelhantes aos obtidos noutras coortes, nomeadamente no que respeita à idade de início, à percentagem de doentes que completou a dieta, às razões da suspensão e à melhoria do comportamento e estado de alerta.Conclusão: Para além do controlo das crises, os doentes tiveram uma marcada melhoria do seu comportamento e estado de alerta. É necessário desenvolver estratégias para aumentar a adesão das famílias à dieta.Ordem dos Médicos2019-12-02info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfapplication/pdfapplication/pdfapplication/vnd.openxmlformats-officedocument.wordprocessingml.documentapplication/vnd.openxmlformats-officedocument.wordprocessingml.documentapplication/vnd.openxmlformats-officedocument.wordprocessingml.documentapplication/vnd.openxmlformats-officedocument.wordprocessingml.documentapplication/pdfhttps://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/12184oai:ojs.www.actamedicaportuguesa.com:article/12184Acta Médica Portuguesa; Vol. 32 No. 12 (2019): December; 760-766Acta Médica Portuguesa; Vol. 32 N.º 12 (2019): Dezembro; 760-7661646-07580870-399Xreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAPenghttps://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/12184https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/12184/5810https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/12184/11329https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/12184/11330https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/12184/11331https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/12184/11332https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/12184/11333https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/12184/11334https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/12184/11551Direitos de Autor (c) 2019 Acta Médica Portuguesainfo:eu-repo/semantics/openAccessRomão Luz, InêsPereira, CristinaGarcia, PaulaFerreira, FátimaFaria, AnaMacedo, CristianeDiogo, LuísaRobalo, Conceição2022-12-20T11:06:32Zoai:ojs.www.actamedicaportuguesa.com:article/12184Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T16:20:09.349706Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv Ketogenic Diet for Refractory Childhood Epilepsy: Beyond Seizures Control, the Experience of a Portuguese Pediatric Centre
Dieta Cetogénica na Epilepsia Infantil Refratária: Para além do Controlo das Crises, Experiência de um Centro Pediátrico Português
title Ketogenic Diet for Refractory Childhood Epilepsy: Beyond Seizures Control, the Experience of a Portuguese Pediatric Centre
spellingShingle Ketogenic Diet for Refractory Childhood Epilepsy: Beyond Seizures Control, the Experience of a Portuguese Pediatric Centre
Romão Luz, Inês
Child
Diet
Ketogenic
Drug Resistant Epilepsy/diet therapy
Portugal
Criança
Epilepsia Resistente a Medicamentos/dietoterapia
Portugal
title_short Ketogenic Diet for Refractory Childhood Epilepsy: Beyond Seizures Control, the Experience of a Portuguese Pediatric Centre
title_full Ketogenic Diet for Refractory Childhood Epilepsy: Beyond Seizures Control, the Experience of a Portuguese Pediatric Centre
title_fullStr Ketogenic Diet for Refractory Childhood Epilepsy: Beyond Seizures Control, the Experience of a Portuguese Pediatric Centre
title_full_unstemmed Ketogenic Diet for Refractory Childhood Epilepsy: Beyond Seizures Control, the Experience of a Portuguese Pediatric Centre
title_sort Ketogenic Diet for Refractory Childhood Epilepsy: Beyond Seizures Control, the Experience of a Portuguese Pediatric Centre
author Romão Luz, Inês
author_facet Romão Luz, Inês
Pereira, Cristina
Garcia, Paula
Ferreira, Fátima
Faria, Ana
Macedo, Cristiane
Diogo, Luísa
Robalo, Conceição
author_role author
author2 Pereira, Cristina
Garcia, Paula
Ferreira, Fátima
Faria, Ana
Macedo, Cristiane
Diogo, Luísa
Robalo, Conceição
author2_role author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Romão Luz, Inês
Pereira, Cristina
Garcia, Paula
Ferreira, Fátima
Faria, Ana
Macedo, Cristiane
Diogo, Luísa
Robalo, Conceição
dc.subject.por.fl_str_mv Child
Diet
Ketogenic
Drug Resistant Epilepsy/diet therapy
Portugal
Criança
Epilepsia Resistente a Medicamentos/dietoterapia
Portugal
topic Child
Diet
Ketogenic
Drug Resistant Epilepsy/diet therapy
Portugal
Criança
Epilepsia Resistente a Medicamentos/dietoterapia
Portugal
description Introduction: Ketogenic diet is a low carbohydrate diet, which can be used as a treatment for refractory childhood epilepsy. The first aim of this study was to evaluate its efficacy, in patients receiving ketogenic diet for at least three months, on epilepsy control, behaviour and awareness. The secondary aims were to evaluate the variation in the number of antiepileptic drugs, reasons for discontinuing the diet and adverse effects.Material and Methods: Retrospective analysis of clinical records of patients who underwent ketogenic diet for refractory epilepsy, from October 2007 to January 2018, in a tertiary pediatric hospital.Results: In the twenty-nine eligible patients, the mean age of initiation was 7.9 years-old (+/– 5.6). Of those, 18 had a ≥ 50% reduction of seizure activity, 19 a marked behaviour improvement and 18 improved awareness. The median number of antiepileptic drugs remained equal for the 15 patients who completed 18 months of treatment (three drugs). The main reason for discontinuing ketogenic diet was a familiar decision. The main adverse effects were hypercholesterolemia (n = 23) and hypertriglyceridemia (n = 21).Discussion: Results were comparable to those of other cohorts, namely age of initiation, proportion of patients completing ketogenic diet, most frequent reasons for stopping and significant improvement of alertness and behavior.Conclusion: Beyond seizure control, patients experienced a marked improvement in behavior and awareness. It is necessary to develop strategies to increase the adherence of families to the diet.
publishDate 2019
dc.date.none.fl_str_mv 2019-12-02
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/12184
oai:ojs.www.actamedicaportuguesa.com:article/12184
url https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/12184
identifier_str_mv oai:ojs.www.actamedicaportuguesa.com:article/12184
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/12184
https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/12184/5810
https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/12184/11329
https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/12184/11330
https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/12184/11331
https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/12184/11332
https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/12184/11333
https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/12184/11334
https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/12184/11551
dc.rights.driver.fl_str_mv Direitos de Autor (c) 2019 Acta Médica Portuguesa
info:eu-repo/semantics/openAccess
rights_invalid_str_mv Direitos de Autor (c) 2019 Acta Médica Portuguesa
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
application/pdf
application/pdf
application/vnd.openxmlformats-officedocument.wordprocessingml.document
application/vnd.openxmlformats-officedocument.wordprocessingml.document
application/vnd.openxmlformats-officedocument.wordprocessingml.document
application/vnd.openxmlformats-officedocument.wordprocessingml.document
application/pdf
dc.publisher.none.fl_str_mv Ordem dos Médicos
publisher.none.fl_str_mv Ordem dos Médicos
dc.source.none.fl_str_mv Acta Médica Portuguesa; Vol. 32 No. 12 (2019): December; 760-766
Acta Médica Portuguesa; Vol. 32 N.º 12 (2019): Dezembro; 760-766
1646-0758
0870-399X
reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1799130650300645376